SURVIVAL BENEFIT OF NEOADJUVANT CHEMOTHERAPY IN RESECTABLE PANCREATIC CANCER - NEED BOTH ENDS OF THE SANDWICH

被引：0
|
作者：
Kim, Rachel C.
Allen, Kara A.
Roch, Alexandra M.
Butler, James
Ceppa, Eugene P.
House, Michael G.
Zyromski, Nicholas J.
Nakeeb, Attila
Schmidt, C. Max
Nguyen, Trang
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1172
引用
收藏
页码：S1510 / S1510
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 392 - 392
  • [42] Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
    Shrestha, Bikram
    Sun, Yifei
    Faisal, Farzana
    Kim, Victoria
    Soares, Kevin
    Blair, Alex
    Herman, Joseph M.
    Narang, Amol
    Dholakia, Avani S.
    Rosati, Lauren
    Hacker-Prietz, Amy
    Chen, Linda
    Laheru, Daniel A.
    De Jesus-Acosta, Ana
    Le, Dung T.
    Donehower, Ross
    Azad, Nilofar
    Diaz, Luis A.
    Murphy, Adrian
    Lee, Valerie
    Fishman, Elliot K.
    Hruban, Ralph H.
    Liang, Tingbo
    Cameron, John L.
    Makary, Martin
    Weiss, Matthew J.
    Ahuja, Nita
    He, Jin
    Wolfgang, Christopher L.
    Huang, Chiung-Yu
    Zheng, Lei
    CANCER MEDICINE, 2017, 6 (07): : 1552 - 1562
  • [43] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Javed, Ammar A.
    Wright, Michael J.
    Siddique, Ayat
    Blair, Alex B.
    Ding, Ding
    Burkhart, Richard A.
    Makary, Martin
    Cameron, John L.
    Narang, Amol
    Herman, Joseph
    Zheng, Lei
    Laheru, Daniel
    Weiss, Matthew J.
    Wolfgang, Christopher
    He, Jin
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (01) : 112 - 121
  • [44] The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
    Yoshihiko Yonekawa
    Kay Uehara
    Takashi Mizuno
    Toshisada Aiba
    Atsushi Ogura
    Toshiki Mukai
    Yukihiro Yokoyama
    Tomoki Ebata
    Yasuhiro Kodera
    Masato Nagino
    International Journal of Clinical Oncology, 2021, 26 : 126 - 134
  • [45] Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?
    Lubezky, Nir
    Geva, Ravit
    Shmueli, Einat
    Nakache, Richard
    Klausner, Joseph M.
    Figer, Arie
    Ben-Haim, Menahem
    WORLD JOURNAL OF SURGERY, 2009, 33 (05) : 1028 - 1034
  • [46] Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?
    Nir Lubezky
    Ravit Geva
    Einat Shmueli
    Richard Nakache
    Joseph M. Klausner
    Arie Figer
    Menahem Ben-Haim
    World Journal of Surgery, 2009, 33 : 1028 - 1034
  • [47] The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
    Yonekawa, Yoshihiko
    Uehara, Kay
    Mizuno, Takashi
    Aiba, Toshisada
    Ogura, Atsushi
    Mukai, Toshiki
    Yokoyama, Yukihiro
    Ebata, Tomoki
    Kodera, Yasuhiro
    Nagino, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 126 - 134
  • [48] OUTCOME OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER IN THE CONTEMPORARY ERA OF NEOADJUVANT CHEMOTHERAPY
    Javed, Ammar A.
    Siddique, Ayat
    Blair, Alex
    Parish, Lindsay
    Burkhart, Richard
    Weiss, Matthew J.
    Cameron, John
    Narang, Amol
    Zheng, Lei
    Laheru, Daniel
    Wolfgang, Christopher L.
    He, Jin
    GASTROENTEROLOGY, 2018, 154 (06) : S1265 - S1265
  • [49] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Ammar A. Javed
    Michael J. Wright
    Ayat Siddique
    Alex B. Blair
    Ding Ding
    Richard A. Burkhart
    Martin Makary
    John L. Cameron
    Amol Narang
    Joseph Herman
    Lei Zheng
    Daniel Laheru
    Matthew J. Weiss
    Christopher Wolfgang
    Jin He
    Journal of Gastrointestinal Surgery, 2019, 23 : 112 - 121
  • [50] Efficacy of Neoadjuvant Chemotherapy Using Gemcitabine and S-1 for Resectable and Borderline Resectable Pancreatic Cancer
    Aoki, T.
    Mori, S.
    Sakuraoka, Y.
    Suzuki, T.
    Nishi, Y.
    Arakawa, T.
    Shimizu, T.
    Tago, K.
    Park, K. H.
    Harada, N.
    Shiraki, T.
    Iso, Y.
    Kubota, K.
    PANCREAS, 2019, 48 (10) : 1404 - 1404
12345